Ładuje się......
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
BACKGROUND: Programmed cell death protein 1 (PD-1) is a key immune checkpoint that regulates peripheral tolerance and protects against autoimmunity. Programmed death ligand-2 (PD-L2) is a less studied ligand to PD-1 and has yet to be fully explored, especially in pancreatic ductal adenocarcinoma (PD...
Zapisane w:
| Wydane w: | J Immunother Cancer |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716876/ https://ncbi.nlm.nih.gov/pubmed/31464648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0703-0 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|